Microbot Medical Inc. (MBOT)

Microbot Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-13.14	-11.44	-10.74	-13.17
Depreciation & Amortization	0.05	0.09	0.11	0.1
Stock-Based Compensation	1.06	1.35	1.39	1.75
Other Adjustments	-	-0	0.72	-0.01
Changes in Inventories	-0.58	-	-	-
Changes in Accrued Expenses	0.5	0.87	-0.68	-0.24
Changes in Other Operating Activities	-0.92	0.3	0.67	0.01
Operating Cash Flow	-13.05	-8.83	-8.53	-11.55
Capital Expenditures	-0.06	-0.03	-0.03	-0.08
Purchases of Investments	-82.93	-5.12	-10.06	-3.75
Proceeds from Sale of Investments	10.6	6.68	12.06	-
Other Investing Activities	-	-	0	-0
Investing Cash Flow	-72.38	1.54	1.97	-3.84
Issuance of Common Stock	86.24	7.94	6.56	4.32
Net Common Stock Issued (Repurchased)	86.24	7.94	6.56	4.32
Financing Cash Flow	86.24	7.94	6.56	4.32
Net Cash Flow	0.81	0.65	-0	-11.06
Free Cash Flow	-13.11	-8.85	-8.57	-11.63
Free Cash Flow Per Share	-0.29	-0.57	-0.84	-1.60
Levered Free Cash Flow	-14.16	-10.2	-10.68	-13.38
Unlevered Free Cash Flow	-15.76	-10.38	-9.79	-13.49

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q